AZN Stock Price History and Quote Analysis: Insights for Investors
AstraZeneca PLC
Stock Price Today
AstraZeneca PLC (AZN) stock declined over -0.18%, trading at $76.73 on NASDAQ, down from the previous close of $76.87. The stock opened at $76.84, fluctuating between $76.42 and $77.00 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company's marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Company Information
| Employees | 89900 |
| Beta | 0.167 |
| Sales or Revenue | $45.81B |
| 5Y Sales Change% | 0.696% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Frequently Asked Questions
AstraZeneca PLC (NASDAQ: AZN) stock price is $76.73 in the last trading session. During the trading session, AZN stock reached the peak price of $77.00 while $76.42 was the lowest point it dropped to. The percentage change in AZN stock occurred in the recent session was -0.18% while the dollar amount for the price change in AZN stock was -$0.14.
The NASDAQ listed AZN is part of Drug Manufacturers - General industry that operates in the broader Healthcare sector. AstraZeneca PLC designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
No Data
AZN's closing price is 27.12% higher than its 52-week low of $60.47 where as its distance from 52-week high of $87.68 is -12.33%.
Number of AZN employees currently stands at 89,900.
Official Website of AZN is: https://www.astrazeneca.com
AZN could be contacted at phone 442 037 495000 and can also be accessed through its website. AZN operates from 1 Francis Crick Avenue, Cambridge, CB2 0AA, United Kingdom.
AZN stock volume for the day was 1.75M shares. The average number of AZN shares traded daily for last 3 months was 4.59M.
The market value of AZN currently stands at $237.91B with its latest stock price at $76.73 and 3.1B of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com